Funds Holding Arena Pharmaceuticals, Inc.

Also showing items for ETFS Holding Arena Pharmaceuticals, Inc.

 
Stock Quotes for Arena Pharmaceuticals, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for arna investment picks

 
News Articles for Arena Pharmaceuticals, Inc. top ^
2013/3/4
-- Conference Call and Webcast Scheduled for Today at 8:30 a.m. Eastern Time --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/2/6
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences investment picks
2013/2/27
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference investment picks
2013/4/1
-- Application for Approval as a Treatment for Chronic Weight Management Triggers $500,000 Milestone Payment to Arena --
Sign-up for Arena Pharmaceuticals Announces Eisai's Submission of BELVIQ® (lorcaserin HCl) Marketing Authorization Application in Mexico investment picks
2013/4/5
SAN DIEGO , April 5, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P 1 ) receptor for the potential treatment of autoimmune diseases.
Sign-up for Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases investment picks
2013/4/26
SAN DIEGO , April 26, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it will provide a corporate update and discuss first quarter 2013 financial results after the NASDAQ Global Select Market closes on Thursday, May 2, 2013 .
Sign-up for Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2 investment picks
2013/5/2
-- Conference Call and Webcast Scheduled for Today at 5:15 p.m. Eastern Time --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results investment picks
2013/5/7
-- Arena to Receive $65 Million in Milestone Payments from Eisai --
Sign-up for Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management investment picks
2013/5/10
SAN DIEGO , May 10, 2013  /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 , at 2:20 p.m. Pacific Time ( 5:20 p.m. Eastern Time ), at the Encore at the Wynn Las Vegas Hotel in Las Vegas, Nevada .
Sign-up for Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/5/24
SAN DIEGO , May 24, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the following investor conferences: Deutsche Bank Securities 38 th Annual Health Care Conference Presentation: May 30, 2013 , at 12:00 p.m. Eastern Time ( 9:00 a.m. Pacific Time ) at The Westin Boston Waterfront Hotel in Boston, Massachusetts Jefferies 2013 Global Healthcare Conference Presentation: June 4, 2013 , at 9:30 a.m. Eastern Time ( 6:30 a.m. Pacific Time ) at the Grand Hyatt New York in New York City A live audio webcast of each presentation will be available under the investor relations section of Arena's website at www.arenapharm.com .
Sign-up for Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences investment picks
2013/6/7
-- BELVIQ Available in US Pharmacies within One Week -- --
Sign-up for Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Arena Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Arctic Cat, Inc.  |  Next: Funds Holding Ariad Pharmaceuticals